ARCA, MARCELLO
 Distribuzione geografica
Continente #
NA - Nord America 117
AS - Asia 100
EU - Europa 47
SA - Sud America 15
AF - Africa 6
OC - Oceania 1
Totale 286
Nazione #
US - Stati Uniti d'America 111
SG - Singapore 58
CN - Cina 17
IT - Italia 17
BR - Brasile 14
DE - Germania 10
FI - Finlandia 5
CA - Canada 4
GB - Regno Unito 4
IN - India 4
NL - Olanda 4
BD - Bangladesh 3
TR - Turchia 3
EG - Egitto 2
HK - Hong Kong 2
ID - Indonesia 2
IR - Iran 2
NP - Nepal 2
SE - Svezia 2
UZ - Uzbekistan 2
ZA - Sudafrica 2
AR - Argentina 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
ES - Italia 1
IL - Israele 1
JM - Giamaica 1
JO - Giordania 1
JP - Giappone 1
LT - Lituania 1
MA - Marocco 1
MX - Messico 1
PL - Polonia 1
RU - Federazione Russa 1
SA - Arabia Saudita 1
TO - Tonga 1
VN - Vietnam 1
Totale 286
Città #
Singapore 46
Boardman 18
Hefei 14
Santa Clara 14
Dallas 12
Los Angeles 9
Munich 7
Ashburn 5
Milan 5
New York 4
Brooklyn 3
Lawrence 3
Princeton 3
São Paulo 3
Amsterdam 2
Ankara 2
Changsha 2
Chennai 2
Des Moines 2
Ghorahi 2
Hong Kong 2
Johannesburg 2
London 2
Phoenix 2
Tashkent 2
Tehran 2
Turku 2
Agadir 1
Amman 1
Araraquara 1
Aylesbury 1
Berlin 1
Boston 1
Cairo 1
Cedar Knolls 1
Charlemont 1
Charlotte 1
Chlef 1
Cincinnati 1
Clarksburg 1
College Park 1
Concord 1
Curitiba 1
Duque de Caxias 1
Eden Prairie 1
Extrema 1
Helsinki 1
Indianapolis 1
Jacksonville 1
Jeddah 1
Jijoca de Jericoacoara 1
Kingston 1
Loma Hermosa 1
Madrid 1
Manchester 1
Marília 1
Montreal 1
Nuku'alofa 1
Nuremberg 1
Olomouc 1
Othello 1
Porteiras 1
Porto Alegre 1
Querétaro City 1
Rio de Janeiro 1
San Jose 1
Santo André 1
Sorrento 1
Suez 1
Temryuk 1
Teverola 1
Tokyo 1
Toronto 1
Vacaria 1
Warsaw 1
Wilmington 1
Totale 221
Nome #
Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia 56
[How to overcome barriers to implementation of prevention and management strategies of atherosclerotic cardiovascular disease through lipid-lowering therapy] 25
Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia 25
Efficacy of Long-Term Treatment of Autosomal Recessive Hypercholesterolemia With Lomitapide: A Subanalysis of the Pan-European Lomitapide Study 24
Appropriateness criteria for the management of lipid-lowering therapy with alirocumab in high cardiovascular risk patients. The opinion of a multidisciplinary group of Italian experts 23
Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia: insights from the Italian LIPIGEN Registry 21
Long-term efficacy of lipoprotein apheresis and lomitapide in the treatment of homozygous familial hypercholesterolemia (HoFH): a cross-national retrospective survey 21
Lipid Lowering Treatment and Eligibility for PCSK9 Inhibition in Post-Myocardial Infarction Patients in Italy: Insights from Two Contemporary Nationwide Registries 19
Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia: insights from the Italian LIPIGEN Registry 18
Refinement of the diagnostic approach for the identification of children and adolescents affected by familial hypercholesterolemia: Evidence from the LIPIGEN study 18
The Role of Registers in Increasing Knowledge and Improving Management of Children and Adolescents Affected by Familial Hypercholesterolemia: the LIPIGEN Pediatric Group 17
Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study 13
Long‐term hepatic safety of lomitapide in homozygous familial hypercholesterolaemia 11
Long-term hepatic safety of lomitapide in homozygous familial hypercholesterolaemia 10
Totale 301
Categoria #
all - tutte 3.332
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.332


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212 0 0 0 0 0 0 0 2 0 0 0 0
2021/20229 0 0 0 2 0 0 1 1 0 3 2 0
2022/20238 6 0 0 0 0 0 0 2 0 0 0 0
2023/202430 0 0 0 1 0 0 1 1 0 2 0 25
2024/2025163 19 3 1 8 11 30 0 2 17 12 21 39
2025/202689 34 44 11 0 0 0 0 0 0 0 0 0
Totale 301